| Name | Title | Contact Details |
|---|
KII Consulting, Inc. works closely with clients as a strategic partner and trusted advisor that offers unique value to clients in customizing solutions in the cyber wellness space.
Aegis Sortation is a technology and innovation leader specializing in the Freight and Parcel, Warehouse and Distribution, and E-Commerce industries. At Aegis we are innovating today to transform industries tomorrow! Innovation is the engine that drives our company forward and generates the creative forces behind everything we do and make. We are dedicated to providing exceptional service for our customers and exceeding industry standards for speed, durability, and safety. Our products are specifically designed to transform business; always, with no exceptions. This approach allows us to take advantage of both tried-and-true practices as well as applicable cutting-edge technologies. Aegis is determined to bring innovation, excellence and results to every project and partnership.
The space between starting a business and scaling one…is TrueSpace. TrueSpace is a professional learning community for Founders and their leadership teams. We teach a new model of business building to change how entrepreneurs use their time, invest capital and lead talent. TrueSpace is the leading authority on the operating conditions necessary to prepare a business for scale. Weve put in the time, money, and hard work to make this claim and have the broadest set of data on companies between $1 - $10M. By joining our community you gain: 1. Predictive Insight - see your business and its potential through a scientific lens 2. Resource Clarity - make more accurate decisions with your use of time, capital, and talent 3. A Curated Community - be a valuable addition to a national network of Business Builders® 4. National Recognition - get discovered by investors, top talent, and potential buyers Apply today at www.truespace.com
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.